Centrillion Technologies

Executive Summary

Centrillion Technologies is a private DNA chip technology company based in Palo Alto, California, founded in 2011. The company has developed proprietary platforms for whole genome genotyping, spatial transcriptomics at micron-scale resolution, and viral detection (VirusHunter™ assays for SARS-CoV-2). Its core innovation lies in reimagining DNA chip technology to enable high-quality, high-resolution genetic analysis. While the company has not disclosed funding or valuation details, its technology addresses key needs in diagnostics, genotyping, and spatial biology. The combination of genotyping and spatial transcriptomics positions Centrillion for applications in precision medicine, infectious disease surveillance, and research. However, the company remains early-stage with limited public information on commercial traction or regulatory milestones.

Upcoming Catalysts (preview)

• Q3 2026Expansion of VirusHunter™ assay portfolio to include other respiratory pathogens60% success
• TBDPartnership or licensing deal for spatial transcriptomics platform with a major research institution40% success